Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Keytruda | pembrolizumab | Merck Sharp & Dohme | N-125514 RX | 2015-01-15 | 1 products |
Expiration | Code | ||
---|---|---|---|
pembrolizumab, Keytruda, Merck Sharp & Dohme LLC | |||
2028-12-03 | Orphan excl. |
Code | Description |
---|---|
J9271 | Injection, pembrolizumab, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 162 | 199 | 59 | 3 | 29 | 382 |
Melanoma | D008545 | — | — | 137 | 142 | 17 | 1 | 29 | 263 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 72 | 104 | 6 | 1 | 8 | 163 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 41 | 40 | 1 | 1 | — | 69 |
Glioblastoma | D005909 | EFO_0000515 | — | 15 | 24 | — | 1 | 1 | 33 |
Thymoma | D013945 | — | — | 1 | — | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 247 | 147 | 5 | — | 12 | 309 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 64 | 88 | 6 | — | 1 | 134 |
Colorectal neoplasms | D015179 | — | — | 67 | 69 | 7 | — | 4 | 120 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 68 | 60 | 9 | — | 6 | 115 |
Triple negative breast neoplasms | D064726 | — | — | 55 | 62 | 8 | — | — | 108 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 44 | 50 | 8 | — | 2 | 83 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 42 | 55 | 3 | — | 1 | 83 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 34 | 41 | 7 | — | 11 | 81 |
Head and neck neoplasms | D006258 | — | — | 32 | 54 | 9 | — | 3 | 81 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 38 | 43 | 10 | — | 6 | 73 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoma | D012509 | — | — | 21 | 25 | — | — | — | 35 |
Lymphoma | D008223 | — | C85.9 | 21 | 13 | — | — | — | 27 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 17 | 14 | — | — | — | 24 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 13 | 16 | — | — | — | 24 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 10 | 12 | — | — | — | 20 |
Follicular lymphoma | D008224 | — | C82 | 11 | 10 | — | — | — | 17 |
Myeloid leukemia acute | D015470 | — | C92.0 | 9 | 9 | — | — | — | 16 |
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | 2 | 11 | — | — | — | 11 |
Pancreatic ductal carcinoma | D021441 | — | — | 3 | 10 | — | — | — | 11 |
Immunotherapy | D007167 | — | — | 2 | 4 | — | — | 5 | 10 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuroblastoma | D009447 | EFO_0000621 | — | 2 | — | — | — | — | 2 |
Rhabdomyosarcoma | D012208 | — | — | 2 | — | — | — | — | 2 |
Lymphoid leukemia | D007945 | — | C91 | 2 | — | — | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | — | — | — | 2 |
Digestive system neoplasms | D004067 | — | — | 2 | — | — | — | — | 2 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | — | — | — | — | 1 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 1 | — | — | — | — | 1 |
Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | — | — | — | 1 |
Leukemia myeloid chronic atypical bcr-abl negative | D054438 | — | C92.2 | 1 | — | — | — | — | 1 |
Thrombocytosis | D013922 | HP_0001894 | D75.83 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Autoimmune diseases | D001327 | HP_0002960 | M30-M36 | — | — | — | — | 3 | 3 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 2 | 2 |
Myocarditis | D009205 | — | I51.4 | — | — | — | — | 2 | 2 |
Interstitial lung diseases | D017563 | HP_0006530 | J84.89 | — | — | — | — | 2 | 2 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 1 | 1 |
Cardiomyopathies | D009202 | EFO_0000318 | I42 | — | — | — | — | 1 | 1 |
Pericarditis | D010493 | EFO_0007427 | I30 | — | — | — | — | 1 | 1 |
Vasculitis | D014657 | HP_0002633 | — | — | — | — | — | 1 | 1 |
Myositis | D009220 | EFO_0000783 | G72.49 | — | — | — | — | 1 | 1 |
Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | — | — | 1 | 1 |
Drug common name | Pembrolizumab |
INN | pembrolizumab |
Description | Pembrolizumab (formerly lambrolizumab, brand name Keytruda) is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein.
|
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | >5GGS:A,C|heavy chain
QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAY
MELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVS
WNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHHHHHH
>5GGS:B,D|light chain
EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTIS
SLEPEDFAVYYCQHSRDLPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQS
GNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 5B8C, 5DK3, 5GGS, 5JXE |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL3137343 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB09037 |
UNII ID | DPT0O3T46P (ChemIDplus, GSRS) |